Hemab Therapeutics Holdings COAG
NASDAQ COAG
$40.86 +1.48 (+3.76%)
At close: Nov 13, 2026 · 4:00 PM EST

Hemab Therapeutics Holdings (COAG) Interest & Investment Income (2025 - 2026)

Updated

Hemab Therapeutics Holdings (COAG) recorded Interest & Investment Income of $3.38 million in Q3 2026, compared with $215,000 a year earlier and up 18.4% from the prior quarter.

Analysis

Hemab Therapeutics Holdings (COAG) Interest & Investment Income (2025 - 2026) Analysis & Trends

On a TTM basis, Hemab Therapeutics Holdings' Interest & Investment Income came in at $7.68 million as of Sep 30, 2026.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 186.00 Mn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 67.00 Mn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Hemab Therapeutics Holdings 1.91 Bn 672.70 Mn - 3.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 3.38 Mn
Jun 30, 2026 2.86 Mn
Mar 31, 2026 1.22 Mn
Sep 30, 2025 215,000.00
Jun 30, 2025 335,000.00
Mar 31, 2025 473,000.00
API Access

Hemab Therapeutics Holdings Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=COAG&period=max&api_key=YOUR_API_KEY